Researchers have developed a new class of ultra-thin, flexible bioelectronic material that can seamlessly interface with ...
A research team at the Center for Neuroscience Imaging Research (CNIR) within the Institute for Basic Science (IBS), together ...
By 8 a.m. Dec. 12, people were already standing outside, waiting to get in line at the fast food restaurant. Fans who camped ...
This is an audio transcript of the Unhedged podcast episode: ‘Can 2026 match 2025?’ ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the ...
Merck , known as MSD outside of the United States and Canada, today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended the approval of an ...
The ASX healthcare sector has logged another week in the red and, without a Christmas miracle, looks set to end 2025 as the ...
IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 12:30 PM ESTCompany ParticipantsShaun Bagai - ...
Daniel Ives You can reverse the age of cells all the way down to zero in just a few weeks. So you can actually take a ...
Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, received investigational device exemption (IDE) approval from ...
Hello, and welcome to Wave Life Sciences Positive Interim Clinical Data from INLIGHT Trial of WVE-007 and Obesity call. [Operator Instructions]. Also, as a reminder, this conference is being recorded ...
Coherus Oncology, Inc. (NASDAQ: CHRS) today announced compelling six-year overall survival (OS) follow-up results from the Phase 3 JUPITER-02 trial evaluating LOQTORZI® (toripalimab-tpzi) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results